Drugs / CHI-921
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03984604 Comparator | Mar 2019 → Jun 2020 | insomnia | Canopy Growth Corporation | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHI-921 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03984604 ↗ |
| Route | Oral | “administered in oral liquid (oil) form” NCT03984604 ↗ |